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Introduction {#s1}
============

Quality in healthcare has different dimensions and elements ([@R1]-[@R4]), of which patient safety (PS) is one of the most important dimensions ([@R5]). PS is a serious global challenge and a very important dimension of healthcare quality ([@R6]-[@R8]). According to WHO, in low and middle income countries (LMIC) one out of ten patients is harmed while receiving health services ([@R9]). Institute of Medicine (IOM) report entitled \"To Err Is Human\" showed that more than 98 thousand patients die in the United States every year as a result of medical errors ([@R10]). For this reason PS has received considerable focus from policy-makers and other stakeholders ([@R11]).

Patient Safety Culture (PSC) is an important factor of PS in healthcare system ([@R12]). The IOM offers that the very important challenge to achieve a safer healthcare system is to improve the PSC ([@R13]). Measurement of PSC is a top priority aim to improve quality of PS ([@R14]-[@R20]). Neiva and Sorra ([@R15]) defined PSC as: "the product of individual and group values, attitudes, perceptions, competencies, and patterns of behavior that determine the commitment to, and the style and proficiency of, an organization\'s safety management". Previous studies results show that there is a positive relationship between high PSC and safety performance in hospitals (good PS) ([@R14],[@R21]).

Globally, several international organizations attempted to promote PSC: the World Alliance for Patient Safety (WAPS), the National Patient Safety Agency (NPSA), the Agency for Healthcare Research and Quality (AHRQ) and the Australia Commission of Safety and Quality (ACSQ) ([@R22]-[@R24]). In this regard, several instruments have been developed to measure PSC ([@R25]-[@R27]). The Hospital Survey on Patient Safety Culture (HSOPSC) of AHRQ is a valid and reliable instrument to measure PSC in the hospitals ([@R28]-[@R31]). This tool is translated to many languages and validated psychometrically ([@R32]-[@R34]).

A review of the literature showed that PSC status in Iranian hospitals is not satisfactory ([@R35]). Thus, the aim of the current study was to clarify PSC status in Iranian hospitals through a meta-analysis of studies which used HSOPSC instrument in Iran.

Methods {#s2}
=======

A Meta-Analysis study was conducted in 2014, and the required data were collected searching following keywords: patient safety, patient safety culture, patient safety climate and its combination with hospital (such as "hospital survey on patient safety culture"), measurement, assessment, survey, and Iran, in Google Scholar, PubMed, Scopus, Cochrane Library, Magiran, Iranian scientific information (SID) and IranMedex. Manual journal and website searching was also conducted. To increase confidence level of identification of the articles, the reference lists of the selected articles were also searched through. Articles published from 2000 to 2014 were recruited.

The inclusion criteria for the study were: articles published in Persian and English languages, articles that measured PSC in hospital, and articles that measured PSC using HSOPSC instrument. Exclusion criteria included: articles that measured overall safety culture, articles that measured PSC in primary healthcare, articles that not measured all dimension of HSOPSC instrument, conference presentations, case reports, and interventional and qualitative studies. Two reviewers evaluated the articles according to the checklist of Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) (Appendix 1).

Of 961 retrieved articles, 11 articles were entered in the study ([Fig. 1](#F1){ref-type="fig"}). After accurately studying and extracting the required data, the extracted data were summarized in the extraction table. Excel 2010 software was used to draw graphs. Endnote X5 software was used for organizing titles and abstracts and also identification of duplication studies ([@R36]). To calculate the overall PSC score, Comprehensive Meta-Analysis (CMA) software v. 2 and to report the results, forest plot were used. In forest plot, the size of each square shows sample size and lines on each side of the square show confidence interval.
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PSC score was calculated based on random model with 95% confidence interval. In random models either all or some of the variables are treated as if they are from random causes. Random model was in contrast to fixed model that demonstrate the observed quantities in regard of explanatory variables which are treated as if the variables are not random.

HSOPSC questionnaire was designed by AHRQ. This instrument has 3 parts, 12 dimensions, 44 items and 2 single questions ([Box. 1](#b1){ref-type="table"}). All of questions are in the 5-point Likert scale ("Strongly disagree" to "Strongly agree") or frequency ("Never" to "Always") ([@R37],[@R38]).

###### HSOPSC instrument dimensions (n = 12)

  ----------------------------------------------------------------- -----------------
  Dimensions                                                        Number of Items
  Outcome measure                                                   
  1\. Overall perception of safety                                  4
  2\. Frequency of incident reporting                               3
  Unit level                                                        
  3\. Supervisor/manger expectations and actions promoting safety   4
  4\. Organizational learning --- continuous improvement            3
  5\. Teamwork within hospital units                                4
  6\. Communication openness                                        3
  7\. Feedback and communication about error                        3
  8\. Non punitive response to error                                3
  9\. Staffing                                                      4
  Hospital level                                                    
  10\. Hospital management support for patient safety               3
  11\. Teamwork across hospital units                               4
  12\. Hospital handoffs and transitions                            4
  Number of incidents reported (last 12 month)                      1
  Patient safety grade                                              1
  ----------------------------------------------------------------- -----------------

Results {#s3}
=======

A total of 11articles initially were reviewed ([@R39]-[@R49]).The characteristics of the reviewed articles are shown in [Table 1](#T1){ref-type="table"}. The overall numbers of participants were 2972 (270 each study).

###### Characteristics of PSC studies that used HSOPSC in Iran

  ---------------------------- ------------- ------ ------ ------- ------ ------ ------ ------ ------ ------ ------ ------ ------ ------------
  References                   Sample size   1\*    2      3       4      5      6      7      8      9      10     11     12     Mean±SD
  Ravaghi et al;2012           216 staff     49.2   65     53.8    62.8   14.8   12.2   44.3   45.8   57.2   37.3   45.4   40.5   44±16.5
  Ebadi fard azar et al;2010   145 staff     64     66     66      67     51     57     62     62     61     63     63     61     61.9±4.3
  Abdi et al: 2010             311 staff     15     19.5   27.5    47.2   17.8   35     24     18.2   19.9   29.7   19.9   14.1   23.9±9.5
  Agharahimi et al:2012        94 staff      62     70.6   72.8    67.6   68.8   59.4   62.2   61.4   59.4   56.4   63.8   63.4   64±4.9
  Boghaei et al.:2010          500 staff     59     69     67      80     31     36     49     55     62     45     56     42     54.25±14.3
  Izadi et al.;2012            196 staff     67     73     76      75     54     48     65     62     69     68     70     66     66±8.2
  Arabloo et a; 2012           145 staff     60     62     61      65     44     47     54     53     60     53     56     58     56.08±6.2
  Moghri et al;2013            725 staff     53     62     55      65     23     35     43     42     48     42     44     46     47±10.3
  Adibi et al; 2012            90 staff      44.6   67.9   51.9    69.8   21.9   26     29.6   29     46.3   50.9   65.9   50.3   46.2±16.6
  Yaghobi Far;2012             207 staff     58.3   69.1   54.15   73.6   13     22.3   52.5   52.6   56.3   37.2   47.4   43.6   48.3±3.6
  Moghri etal; 2012            343 staff     55     66     54      69     18     23     34     40     47     39     41     42     44±5.4
  ---------------------------- ------------- ------ ------ ------- ------ ------ ------ ------ ------ ------ ------ ------ ------ ------------

\*1- Overall perception of safety, 2- Organizational learning/continuous improvement, 3- Supervisor/manager expectations & actions promoting safety,4- Teamwork within hospital units, 5- Non-punitive response to error, 6- Staffing, 7- Hospital management support for patient safety, 8- Teamwork across hospital units, 9- Hospital handoffs & transitions, 10- Communication openness, 11- Feedback & communication about error, 12- Adverse event reporting & recording, \*\*including wide range of health care provider in hospital such as: physicians, nurses, clinical and non-clinical staff, pharmacy and laboratory staff, supervisors and hospital managers

The PSC score based on the random effect model was determined to be 50.1% (95% confidence interval, lower limit= 43.4%, upper limit= 56.9%, I^2^= 99.8, Q-value= 5716.2, df = 10, and p\< 0.001) ([Fig. 2](#F2){ref-type="fig"}).
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In this study due to high heterogeneity, sensitive analysis was done by excluding one of the studies (Abdi et al, 2010). Finally, after excluding this study, the PSC score changed to 52.8% (95% confidence interval, lower limit= 48%, upper limit= 57.6%, I^2^=96.8, Q-value= 3456.2, df = 9, p\< 0.001) ([Fig. 3](#F3){ref-type="fig"}). Mean of dimensions of HSOPSC questionnaire are shown in [Fig. 4](#F4){ref-type="fig"}.
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As shown in [Fig. 4](#F4){ref-type="fig"}, "Teamwork within hospital units" dimension has the highest score of PSC (67.4%) and "Non-punitive response to error" has the lowest score (32.4%).

Mean of PSC status (excellent, very good, acceptable, poor, failing) in HSOPSC questionnaire are shown in [Fig. 5](#F5){ref-type="fig"}. Accordingly, "very good" grade has the highest mean (%32.3) and "excellent" the lowest (%8.3).
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Mean of reporting number of adverse events in the past 12 months are shown in [Fig. 6](#F6){ref-type="fig"}, which shows that approximately %52.7 of participants did not report any adverse event in the past 12 months.
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Funnel plot of PSC shows that there is no symmetry in gathered data ([Fig. 7](#F7){ref-type="fig"}).
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Discussion {#s4}
==========

The HSOPSC questionnaire has been used to measure PSC in the High Income Countries (HICs), especially, the United States. In present study, we systematically reviewed the PSC status in Iran using studies that administered HSOPSC tool.

Overall, the mean response rate for the 12 PSC dimensions of the HSOPSC questionnaire in Iranian hospitals was 50.5%. This was lower than many of other previous studies, especially in HICs ([@R15],[@R16],[@R50]-[@R54]). Also mean response rate in some studies in LMIC was higher compared to that of current study ([@R55]-[@R57]).

Furthermore, the ﬁndings of this study demonstrated that \"non-punitive response to error\" dimension has lowest score among 12 dimensions of the HSOPSC questionnaire. Similar results were found in previous studies ([@R57]-[@R59]). van Geest and Cummings' study showed that absence of a non-punitive response system to errors is an important barrier for identiﬁcations and reduction of errors in healthcare setting ([@R60]).Non-punitive response system defined as \"the extent to which personnel feel that their mistakes are not held against them and that mistakes are not recorded in their personnel document\" ([@R61]). Punitive response system can lead to underreporting adverse events in hospitals. Unreserved system is an effective method for risk reduction in hospitals, which can start with adverse event reporting without punishing, and continue with encourage to report and learning from adverse events.

The present study revealed that about 41% of participants evaluate their hospitals' PSC status as 'excellent /very good'. El-Jardali and colleagues study in Lebanese hospitals demonstrated that about 70% of participants evaluated their hospitals PSC status as 'excellent/very good' ([@R55]). One study reported a higher 'excellent/very good' for PSC than this study ([@R62],[@R63]).

According to the reviewed articles in this study, about 52% of participants did not report any adverse event in the past 12 months. Contrary to this study, El-Jardali and colleagues showed that about 60% of participants did not completed any event in the past 12 months ([@R55]). Also, Jasti and colleagues showed that 64% of internal medicine house staff in academic teaching hospital did not report an adverse event in the past 12 months ([@R62]). Possible reasons for lower rate of reporting adverse events in current study might be the followings: no adverse event occurred in the hospitals during this period; or, staff did not report adverse events due to punishment system in the hospitals. The first reason seems to be impossible due to frequent reports of adverse events or medical errors in the hospitals ([@R64]-[@R66]). Therefore, hospitals managers better off to change current punishment system into participating system for improvement of PS. Hospital managers should try to remove scold, fear and silence from their system ([@R67]).

According to published years of reviewed articles in this study (from 2010 to 2013), it revealed that PSC is a very new concept in Iranian hospitals and unfortunately this issue has been neglected. In Iran, the PSC received attention due to PS friendly hospital initiatives since 2010, which was started in 10 hospitals and recently, Ministry of Health and Medical Education (MOHME) has decided to expand this program to 50 more hospitals ([@R68]). Also from 2009 in Iranian healthcare system, Clinical governance has been introduced as a framework to quality improving of hospitals services ([@R69],[@R70]). These and other similar programs such as hospital accreditation are very useful and important for PSC improvement, but, it should be noted that improvement of PSC in hospitals and other organizations is highly related to Continues Quality Improvement (CQI) culture, organization leadership commitment, creating learning atmosphere in hospitals and a customer-oriented culture in hospitals in long-run.

The present study has some limitations such as no access to some of databases, and that, included articles were conducted only in hospitals.

Conclusion {#s5}
==========

Nowadays, measuring PSC in healthcare organizations is being increasingly welcome, especially in the HICs, and by Iranian hospitals. In this regard, review of related studies showed that Iranian hospitals' performance in PSC filed is weak. Hence, improving PSC should be prioritized in Iranian hospitals. In this regard hospitals staff should be encouraged to report adverse events without fear of punishment.

Prevalence Critical Appraisal Instrument {#s7-1}
========================================

###### STROBE Statement-checklist of items that should be included in reports of observational studies

  --------------------------- --------- ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
                              Item No   Recommendation

  Title and abstract          1         \(a\) Indicate the study's design with a commonly used term in the title or the abstract

                                        \(b\) Provide in the abstract an informative and balanced summary of what was done and what was found

  Introduction                          

  Background/rationale        2         Explain the scientific background and rationale for the investigation being reported

  Objectives                  3         State specific objectives, including any prespecified hypotheses

  Methods                               

  Study design                4         Present key elements of study design early in the paper

  Setting                     5         Describe the setting, locations, and relevant dates, including periods of recruitment, exposure, follow-up, and data collection

  Participants                6         \(a\) Cohort study---Give the eligibility criteria, and the sources and methods of selection of participants. Describe methods of follow-up\
                                        Case-control study---Give the eligibility criteria, and the sources and methods of case ascertainment and control selection. Give the rationale for the choice of cases and controls\
                                        Cross-sectional study---Give the eligibility criteria, and the sources and methods of selection of participants

                                        (b)Cohort study---For matched studies, give matching criteria and number of exposed and unexposed\
                                        Case-control study---For matched studies, give matching criteria and the number of controls per case

  Variables                   7         Clearly define all outcomes, exposures, predictors, potential confounders, and effect modifiers. Give diagnostic criteria, if applicable

  Data sources/ measurement   8\*       For each variable of interest, give sources of data and details of methods of assessment (measurement). Describe comparability of assessment methods if there is more than one group

  Bias                        9         Describe any efforts to address potential sources of bias

  Study size                  10        Explain how the study size was arrived at

  Quantitative variables      11        Explain how quantitative variables were handled in the analyses. If applicable, describe which groupings were chosen and why

  Statistical methods         12        \(a\) Describe all statistical methods, including those used to control for confounding

                                        \(b\) Describe any methods used to examine subgroups and interactions

                                        \(c\) Explain how missing data were addressed

                                        \(d\) Cohort study---If applicable, explain how loss to follow-up was addressed\
                                        Case-control study---If applicable, explain how matching of cases and controls was addressed\
                                        Cross-sectional study---If applicable, describe analytical methods taking account of sampling strategy

                                        \(e\) Describe any sensitivity analyses

                                        

                                        

  Result                                

  Participants                13\*      \(a\) Report numbers of individuals at each stage of study---eg numbers potentially eligible, examined for eligibility, confirmed eligible, included in the study, completing follow-up, and analyzed

                                        \(b\) Give reasons for non-participation at each stage

                                        \(c\) Consider use of a flow diagram

  Descriptive data            14\*      \(a\) Give characteristics of study participants (eg demographic, clinical, social) and information on exposures and potential confounders

                                        \(b\) Indicate number of participants with missing data for each variable of interest

                                        \(c\) Cohort study---Summarize follow-up time (eg, average and total amount)

  Outcome data                15\*      Cohort study---Report numbers of outcome events or summary measures over time

                                        Case-control study---Report numbers in each exposure category, or summary measures of exposure

                                        Cross-sectional study---Report numbers of outcome events or summary measures

  Main results                16        \(a\) Give unadjusted estimates and, if applicable, confounder-adjusted estimates and their precision (eg, 95% confidence interval). Make clear which confounders were adjusted for and why they were included

                                        \(b\) Report category boundaries when continuous variables were categorized

                                        \(c\) If relevant, consider translating estimates of relative risk into absolute risk for a meaningful time period

  Other analyses              17        Report other analyses done---eg analyses of subgroups and interactions, and sensitivity analyses

  Discussion                            

  Key results                 18        Summarize key results with reference to study objectives

  Limitations                 19        Discuss limitations of the study, taking into account sources of potential bias or imprecision. Discuss both direction and magnitude of any potential bias

  Interpretation              20        Give a cautious overall interpretation of results considering objectives, limitations, multiplicity of analyses, results from similar studies, and other relevant evidence

  Generalizability            21        Discuss the generalizability (external validity) of the study results

  Other information                     

  Funding                     22        Give the source of funding and the role of the funders for the present study and, if applicable, for the original study on which the present article is based
  --------------------------- --------- ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

\*Give information separately for cases and controls in case-control studies and, if applicable, for exposed and unexposed groups in cohort and cross-sectional studies.

Note: An Explanation and Elaboration article discusses each checklist item and gives methodological background and published examples of transparent reporting. The STROBE checklist is best used in conjunction with this article (freely available on the Web sites of PLoS Medicine at <http://www.plosmedicine.org/>, Annals of Internal Medicine at <http://www.annals.org/>, and Epidemiology at <http://www.epidem.com/>). Information on the STROBE Initiative is available at www.strobe-statement.org
